These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24581181)

  • 1. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
    Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
    BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
    Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
    COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular cadmium in the bronchoalveolar space of long-term tobacco smokers with and without COPD and its association with inflammation.
    Sundblad BM; Ji J; Levänen B; Midander K; Julander A; Larsson K; Palmberg L; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1005-13. PubMed ID: 27274222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Freeman CM; Crudgington S; Stolberg VR; Brown JP; Sonstein J; Alexis NE; Doerschuk CM; Basta PV; Carretta EE; Couper DJ; Hastie AT; Kaner RJ; O'Neal WK; Paine R; Rennard SI; Shimbo D; Woodruff PG; Zeidler M; Curtis JL
    J Transl Med; 2015 Jan; 13():19. PubMed ID: 25622723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
    Traves SL; Culpitt SV; Russell RE; Barnes PJ; Donnelly LE
    Thorax; 2002 Jul; 57(7):590-5. PubMed ID: 12096201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
    Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
    J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.
    Gao J; Ohlmeier S; Nieminen P; Toljamo T; Tiitinen S; Kanerva T; Bingle L; Araujo B; Rönty M; Höyhtyä M; Bingle CD; Mazur W; Pulkkinen V
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L17-26. PubMed ID: 25979078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
    Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
    APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
    Ji J; von Schéele I; Bergström J; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
    Respir Res; 2014 Aug; 15(1):104. PubMed ID: 25155252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
    Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
    J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
    Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
    Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD.
    Holz O; Roepcke S; Watz H; Tegtbur U; Lahu G; Hohlfeld JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1393-402. PubMed ID: 26229458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD.
    Rytilä P; Rehn T; Ilumets H; Rouhos A; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respir Res; 2006 Apr; 7(1):69. PubMed ID: 16646959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
    Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
    BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
    Hacievliyagil SS; Mutlu LC; Temel İ
    Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.